ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.147,12
0,31%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Nascent Biotech Inc (QB) (NBIO)

  7. Nascent Biotech Inc (QB) (NBIO) News

NBIO

Nascent Biotech (QB) (NBIO)

Nascent Biotech Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:NBIO
DatumZeitQuelleÜberschriftSymbolFirma
27/02/202419h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
27/02/202419h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
14/02/202420h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
19/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
09/11/202320h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
09/11/202320h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
09/11/202320h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
06/09/202319h54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
18/08/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
14/08/202322h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:NBIONascent Biotech Inc (QB)
14/07/202320h37Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
14/07/202314h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
03/07/202323h15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:NBIONascent Biotech Inc (QB)
29/06/202318h27Edgar (US Regulatory)Annual Report (10-k)USOTC:NBIONascent Biotech Inc (QB)
29/06/202318h26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:NBIONascent Biotech Inc (QB)
09/06/202321h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
09/06/202321h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
09/06/202321h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
30/05/202312h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
09/05/202314h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
14/04/202319h52Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:NBIONascent Biotech Inc (QB)
14/02/202312h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
02/02/202321h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
02/02/202318h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
26/01/202312h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
10/11/202223h10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NBIONascent Biotech Inc (QB)
28/09/202222h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
27/09/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:NBIONascent Biotech Inc (QB)
09/09/202223h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
09/09/202212h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:NBIONascent Biotech Inc (QB)
 Showing the most relevant articles for your search:USOTC:NBIO

Kürzlich von Ihnen besucht

BIT
UB30F6
UniCredit Bank
GATE
TEMUSDT
TempleCoin
ASX
ACRCD
EU
1136T
1136T
LSE
80LJ
Bbva Intl.a7.2%
TSXV
PUP
GATE
WITBTC
Witnet
EU
NL0015001XZ6
Kingdom of Netherlands B...
TSX
5587
Inbound Platform
NASDAQ
KBWR
Invesco KBW Regional Ban...
TSXV
BOY
NYSE
DCUE
Dominion Energy
BIT
P1M9T8
BNP Paribas Issuance
COIN
LEOCEUR
COIN
SILKKUST
Silk
USOTC
CSUAY
China Shenhua Energy (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten